Kevin M. Prise

Also affiliated with The Northern Ireland Cancer Centre

MedicinePhysics and AstronomyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells”.

New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells

European Journal of Pharmacology(2009)10.1016/j.ejphar.2009.09.068

N/A

0.614DataRank · unranked

59 citations

Kevin M. Prise, Susanne Burdak-Rothkamm

Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions

Physics in Medicine and Biology(2020)10.1088/1361-6560/ab9159

N/A

0DataRank · unranked

154 citations

Alexander F. Bagley, Ross Berbeco, Kyle Bromma, Karl T. Butterworth, Hilary L. Byrne +37 more